◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › G › GALT

Galectin Therapeutics Inc. - (GALT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NASDAQ · DATA UPDATED 2026-10-03

Galectin Therapeutics Inc. - (GALT) operates in the NASDAQ industry and is headquartered in Norcross, United States with about 9 employees. Its market capitalization is roughly $335 million. In the fiscal year ended 2025-12-31, GALT reported $0M in revenue and ($31M) in net income.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer.

Interactive charts & full statements →

GALT Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M—————
Gross Profit——$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M——($5M)($6M)($7M)
Gross Margin %—————————————————————
Operating Income (EBIT)($16M)($20M)($42M)($38M)($38M)($30M)($23M)($13M)($14M)($16M)($21M)($20M)($15M)($12M)($10M)($10M)($5M)($6M)($5M)($6M)($7M)
Operating Margin %—————————————————————
Net Income($28M)($31M)($47M)($41M)($39M)($31M)($23M)($13M)($14M)($16M)($21M)($20M)($16M)($12M)($10M)($11M)($6M)($7M)($3M)($9M)($3M)
Net Margin %—————————————————————
EBITDA($14M)($23M)($41M)($38M)($38M)($30M)($23M)($13M)($14M)($16M)($21M)($20M)($15M)($12M)($10M)($11M)($6M)($7M)($3M)($9M)($1M)
Earnings Per Share (EPS)$-0.43$-0.48$-0.76$-0.68$-0.65$-0.52$-0.41$-0.25$-0.35$-0.46$-0.73$-0.83$-0.72$-0.72$-0.64$-0.91$-0.60$-0.93$-0.40$-1.45$-0.67
Shares Outstanding (M)66M64M62M60M59M59M57M52M39M36M29M24M22M17M15M12M9M8M8M6M5M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GALT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$0M$0M$0M$0M$0M$0M$0M$0M
Gross Profit—$0M$0M—$0M$0M$0M$0M
Gross Margin %——————-27.8%—
Operating Income (EBIT)($4M)($4M)($3M)($4M)($5M)($8M)($12M)($9M)
Operating Margin %——————-34522.2%—
Net Income($9M)($5M)($6M)($8M)($8M)($10M)($12M)($11M)
Net Margin %——————-33241.7%—
EBITDA($1M)($3M)($4M)($6M)($6M)($8M)($10M)($10M)
Earnings Per Share (EPS)$-0.14$-0.08$-0.09$-0.13$-0.12$-0.15$-0.19$-0.18
Shares Outstanding (M)66M66M64M64M63M63M63M62M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GALT Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)($16M)($24M)($42M)($33M)($31M)($24M)($21M)($11M)($10M)($16M)($16M)($17M)($12M)($7M)($8M)($6M)($3M)($4M)($5M)($5M)($7M)
Capital Expenditures (CapEx)$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M
Free Cash Flow (FCF)($16M)($24M)($42M)($33M)($31M)($24M)($21M)($11M)($10M)($16M)($16M)($17M)($12M)($7M)($8M)($6M)($3M)($4M)($5M)($6M)($7M)
FCF Margin %—————————————————————
Dividends Paid—$0M$0M$0M$0M$0M$0M$0M$1M$1M$1M$1M$1M$1M$0M$2M$2M$0M———

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GALT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($2M)($4M)($6M)($4M)($7M)($8M)($13M)($9M)
Free Cash Flow (FCF)($2M)($4M)($6M)($4M)($7M)($8M)($13M)($9M)
FCF Margin %——————-35530.6%—
Dividends Paid—$0M$0M$0M—$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GALT Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$15M$20M$17M$28M$21M$42M$30M$48M$9M$4M$16M$26M$30M$11M$10M$7M$6M$0M$1M$2M$6M
Cash & Cash Equivalents$13M$18M$15M$26M$19M$40M$27M$47M$8M$3M$15M$26M$29M$10M$9M$6M$6M$0M$0M$1M$1M
Total Liabilities$152M$146M$121M$88M$53M$39M$5M$3M$2M$3M$4M$1M$2M$2M$2M$2M$8M$5M$1M$5M$6M
Total Debt (Short + Long-Term)$138M$134M$106M$72M$40M$29M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$1M$0M$0M$0M$0M
Total Shareholders' Equity($137M)($126M)($103M)($60M)($32M)$3M$24M$46M$7M$1M$12M$25M$28M$8M$8M$4M($2M)($4M)$0M($3M)$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GALT viewer.

Other Companies in Software & IT Services

← GALLANTTAll “G” companiesGALX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.